Trials / Unknown
UnknownNCT06246175
A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects
A Multi-center, Single-dose, Open-label, Parallel Design, Pharmacokinetics Study of HRS9531injection in Healthy Subjects and Subjects With Impaired Renal Function
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess how fast HRS9531 gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS9531 | Receive a single dose of HRS9531 injection |
Timeline
- Start date
- 2024-02-28
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
- First posted
- 2024-02-07
- Last updated
- 2024-03-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06246175. Inclusion in this directory is not an endorsement.